“…The management of EM is based on the disease severity, especially the mucosal involvements, the clinical course, and the possible inciting factors. Symptomatic treatment may be sufficient for mild EM, antiviral therapy, systemic corticosteroids, or other immunomodulatory therapies like azathioprine, mycophenolate mofetil, dapsone, thalidomide, and Janus kinase inhibitors can be considered in severe or recurrent cases 1,4 …”